Other languages Qiagen N.V.

Equities

Real-time Estimate Cboe BZX Other stock markets 11:37:37 2024-05-28 am EDT			5-day change	1st Jan Change
43.07 ^USD	-1.51%		-4.33%	-3.80%

May. 21	QIAGEN NV : Berenberg maintains a Buy rating	ZD
May. 15	Qiagen's Updated Clinical Decision Support Platform Secures EU Certification	MT

Qiagen's Updated Clinical Decision Support Platform Secures EU Certification	May. 15
NACHBÖRSE/XDAX +0,3% auf 18.770 Pkt - Schott Pharma stürzen ab	May. 14
Qiagen erhält EU-Zulassung für Clinical Insight Interpret	May. 14
QIAGEN Receives European IVDR Certification for QIAGEN Clinical Insight Interpret	May. 14
Qiagen Receives FDA Clearance for Clinical Use of Respiratory Infection Test	May. 13
Qiagen Obtains US FDA Clearance for Respiratory Syndromic Testing Panel	May. 13
Qiagen, US FBI to Jointly Develop Digital PCR Assay for Forensics	May. 08
QIAGEN Partners with FBI to Develop Digital PCR Assay for QIAcuity for Use in Forensics	May. 07
QIAGEN Announces the Availability of QCI Secondary Analysis	May. 02
QIAGEN : A decent start to 2024; guidance unchanged	Apr. 30
Dpa-AFX-Überblick: UNTERNEHMEN vom 30.04.2024 - 15.15 Uhr	Apr. 30
Qiagen Seeks Acquisitions	Apr. 30
Qiagen wittert Chance auf Erholung - Jahresauftakt noch belastet	Apr. 30
COMPANY TALK/Qiagen sieht sich nach Bolt-on-Akquisitionen um	Apr. 30
COMPANY TALK/Qiagen rechnet 2024 mit Negativwachstum in China	Apr. 30
Knapp behauptet - Zahlenflut im Blick	Apr. 30
Wenig verändert - Zahlenflut vor Preisdaten	Apr. 30
VERGLEICH / Qiagen - 1Q 2024 Eckdaten, Prog. & Ausblick (Wdh.)	Apr. 30
TAGESVORSCHAU/Dienstag, 30. April	Apr. 30
Qiagen Q1 Adjusted Earnings, Sales Decline; Q2 Outlook Issued, 2024 Guidance Affirms -- Shares Fall After Hours	Apr. 29

No results for this search

QIAGEN : A decent start to 2024; guidance unchanged

April 30, 2024 at 09:32 am EDT